![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » SIRS-Lab Acquires Rights of Use to OGT Biochip Technology
SIRS-Lab Acquires Rights of Use to OGT Biochip Technology
March 18, 2005
The biotech company SIRS-Lab and the Oxford Gene Technology IP have agreed on the licensing of OGT's technology for nucleotide-based biochips. The contract signed in January enables SIRS-Lab to produce biochips using the patented technology and to distribute these products and related services Europe-wide.
Le Figaro (http://bourse.lefigaro.fr/Actualite/Default.asp?Source=PR&NumArticle=99551)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct